Parabilis Medicines (PBLS) vs Telix Pharmaceuticals (TLX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Telix Pharmaceuticals is the larger company by market cap ($3.74 billion vs $3.53 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PBLS | TLX |
|---|---|---|
| Share price | $28.59 | $11.02 |
| Market cap | $3.53B | $3.74B |
| 1-day change | -0.80% | -0.91% |
| YTD return | — | +48.46% |
| 1-year return | — | +11.76% |
| P/E ratio (TTM) | — | 110.19 |
| EPS (TTM) | $-9.51 | $0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $803.79M |
| Revenue growth (YoY) | — | +55.61% |
| Net income (latest FY) | — | $-7.13M |
| Gross margin | — | 53.05% |
| Operating margin | — | 3.70% |
| Net margin | — | -0.89% |
| 52-week high | $42.49 | $13.11 |
| 52-week low | $24.51 | $6.28 |
| Distance from 52-week high | -32.71% | -15.95% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +46.03% | +85.32% |
| Average volume | 675.43K | 258.23K |
| Shares outstanding | 121.95M | 339.78M |
| Employees | 145 | 1,120 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Parabilis Medicines
PBLS stock →Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
About Telix Pharmaceuticals
TLX stock →Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,120 employees
PBLS vs TLX FAQ
Which is bigger, Parabilis Medicines or Telix Pharmaceuticals?
Telix Pharmaceuticals (TLX) is larger, with a market capitalization of $3.74B compared with $3.53B for Parabilis Medicines (PBLS).
Are Parabilis Medicines and Telix Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.